Atul Varadhachary from 909 Mulberry Ln, Bellaire, TX 77401, age 61, Phone: 713 660-8931

Name / Title

Company / Classification

Phones & Addresses

Atul Varadhachary
Director, President

V-FAM INC
Business Services at Non-Commercial Site

909 Mulberry Ln, Bellaire, TX 77401

Atul Varadhachary
DIRECTOR

Indo-American Chamber of Commerce of Greater Houston
International Trade and Development

1535 W Loop S SUITE 200, Houston, TX 77027
8 Greenway Plz SUITE 910, Houston, TX 77046

Atul Varadhachary
Director

PRATHAM, USA
Membership Organization

9703 Richmond Ave STE 102, Houston, TX 77042
5890 Pt West Dr, Houston, TX 77036
713 774-9599

Atul Varadhachary
Manager

AVID CHEMOTHERAPEUTICS, LLC
Commercial Physical Research, Nsk

3900 Essex Ln STE 575, Houston, TX 77027

Atul Varadhachary
Manager

EXOTECT, LLC
Commercial Physical Research, Nsk

3900 Essex Ln STE 575, Houston, TX 77027

Atul Varadhachary
Manager

ACF PHARMACEUTICALS, LLC
Mfg Pharmaceutical Preparations

3900 Essex Ln STE 1200, Houston, TX 77027

Atul Varadhachary
Manager

GUIDABOT, LLC
Ret Misc Merchandise

3900 Essex Ln STE 1200, Houston, TX 77027

Atul Varadhachary
President

RELIANCE LIFE SCIENCES, INC

2000 W Sam Houston Pkwy S #700, Houston, TX 77042

Us Patents

Lactoferrin In The Treatment Of Diabetes Mellitus
view source
US Patent:

7034126, Apr 25, 2006
Filed:

May 13, 2004
Appl. No.:

10/844865
Inventors:

Jose Engelmayer - Houston TX, US
Atul Varadhachary - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/40
A61K 49/00
US Classification:

530400, 530350, 530395, 514 12, 514 8, 514 6, 424 91, 424 851
Abstract:

The present invention relates to methods of using a composition of lactoferrin for the treatment of diabetes mellitus as manifested by a reduction in the levels of serum glucose, blood pressure, obesity, or glycosylated hemoglobin (HbAlc).

Composition Of Lactoferrin Related Peptides And Uses Thereof
view source
US Patent:

7183381, Feb 27, 2007
Filed:

Oct 26, 2005
Appl. No.:

11/258767
Inventors:

Atul Varadhachary - Houston TX, US
Peter Glynn - Houston TX, US
Karel Petrak - Houston TX, US
Jose Engelmayer - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

C07K 1/00
US Classification:

530350
Abstract:

The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.

Oral Lactoferrin In The Treatment Of Respiratory Disorders
view source
US Patent:

7238661, Jul 3, 2007
Filed:

May 20, 2003
Appl. No.:

10/441329
Inventors:

Peter Glynn - Houston TX, US
Atul Varadhachary - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/16
A61K 31/195
US Classification:

514 6, 514566
Abstract:

The present invention relates to methods of treating an allergic or non-allergic respiratory disorder by administering orally a composition of lactoferrin alone or in combination with metal chelators to treat respiratory disorders.

Lactoferrin In The Reduction Of Pain
view source
US Patent:

7323443, Jan 29, 2008
Filed:

Dec 11, 2003
Appl. No.:

10/733621
Inventors:

Atul Varadhachary - Houston TX, US
Karel Petrak - Houston TX, US
Assignee:

Agennix Inc. - Houston TX
International Classification:

A61K 38/00
A61K 38/40
US Classification:

514 6, 514 8, 530350, 530395, 530400, 424 91, 424 851
Abstract:

The present invention relates to methods of using lactoferrin (LF) to reduce pain in conditions associated with severe or intractable pain by administering a composition of lactoferrin either alone or in combination with other therapy for pain.

Composition Of Lactoferrin Related Peptides And Uses Thereof
view source
US Patent:

7420033, Sep 2, 2008
Filed:

Feb 22, 2007
Appl. No.:

11/677796
Inventors:

Atul Varadhachary - Houston TX, US
Peter Glynn - Houston TX, US
Karel Petrak - Houston TX, US
Jose Engelmayer - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/00
US Classification:

530324
Abstract:

The present invention is directed to a composition consisting of a series of novel biologically active 33-mer peptides.

Lactoferrin Compositions And Methods Of Wound Treatment
view source
US Patent:

7524814, Apr 28, 2009
Filed:

Sep 16, 2003
Appl. No.:

10/663258
Inventors:

Jose Engelmayer - Houston TX, US
Atul Varadhachary - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/00
A61K 38/40
US Classification:

514 6, 514 8, 530350, 530395, 530400, 424 851, 424 91
Abstract:

The present invention relates to lactoferrin compositions and methods of using the compositions to treat wounds. The compositions can be administered alone or in combination with other standard wound healing therapies.

Lactoferrin As An Agent In The Prevention Of Organ Transplant Rejection And Graft-Versus-Host-Disease
view source
US Patent:

7592306, Sep 22, 2009
Filed:

Dec 10, 2003
Appl. No.:

10/732429
Inventors:

Atul Varadhachary - Houston TX, US
Federica Pericle - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/40
US Classification:

514 2, 514 6, 514 23
Abstract:

The present invention relates to methods of using lactoferrin (LF) to treat, prevent or reduce the incidence of organ transplant rejection and graft-versus-host-disease. More particularly, the present invention relates to methods of reducing an immune response against miss-matched transplanted organs such as kidney, heart, lung, liver, pancreas and stem cells by administering a composition of lactoferrin to the recipient patients. In addition, this invention relates to the treatment of bone marrow transplant (BMT) donors with lactoferrin to attenuate the development of graft-versus-host-disease in the recipients. Moreover, this invention relates to the treatment of xenograft organ donors with lactoferrin to attenuate the development of graft rejection in the recipients.

Lactoferrin In The Reduction Of Pain
view source
US Patent:

7638487, Dec 29, 2009
Filed:

Nov 29, 2007
Appl. No.:

11/947345
Inventors:

Atul Varadhachary - Houston TX, US
Karel Petrak - Houston TX, US
Assignee:

Agennix, Inc. - Houston TX
International Classification:

A61K 38/00
A61K 38/40
US Classification:

514 6, 514 8, 530350, 530395, 530400, 424 91, 424 851
Abstract:

The present invention relates to methods of using lactoferrin (LF) to reduce pain in conditions associated with severe or intractable pain by administering a composition of lactoferrin either alone or in combination with other therapy for pain.

Resumes

Managing Partner

view source

Location:

909 Mulberry Ln, Bellaire, TX 77401

Industry:

Biotechnology

Work:

AlphaDev, LLC - Houston, Texas Area since Jun 2013
Managing Partner
Pulmotect, Inc. since Sep 2012
Member, Board of Directors
TiE - Houston since Jan 2013
Charter Member
Center for Public Policy Priorities - Austin, Texas Area since May 2013
Member Board of Directors
Baylor College of Medicine since 2003
Adjunct Professor

Education:

The Johns Hopkins University School of Medicine 1987 - 1992
University of Mumbai 1981 - 1987

Skills:

Biotechnology
Lifesciences
Drug Development
Clinical Development
Clinical Trials
Pharmaceutical Industry
Cancer
Start Ups
Life Sciences
Biopharmaceuticals
Strategy
Clinical Research
Healthcare
Infectious Diseases
Entrepreneurship
Biochemistry
Cro
Leadership
Oncology
Commercialization
Pharmacology
Medical Devices
Hospitals
Technology Transfer
Venture Capital
Board of Directors
Immunology
Operations Management
Drug Discovery
Non Profits
Informatics
Regulatory Affairs
Molecular Biology
Cell Biology
Medicine
R&D
Corporate Development
Nonprofits
Governance
Genomics
Neuroscience
Vaccines
Neurology
Hematology
Genetics
Diabetes
Animal Models
Early Stage Startups
Fda
Innovation

Atul Varadhachary

view source

Atul Varadhachary

Atul Varadhachary Phones & Addresses

Work

Education

Us Patents

Lactoferrin In The Treatment Of Diabetes Mellitus

Composition Of Lactoferrin Related Peptides And Uses Thereof

Oral Lactoferrin In The Treatment Of Respiratory Disorders

Lactoferrin In The Reduction Of Pain

Composition Of Lactoferrin Related Peptides And Uses Thereof

Lactoferrin Compositions And Methods Of Wound Treatment

Lactoferrin As An Agent In The Prevention Of Organ Transplant Rejection And Graft-Versus-Host-Disease

Lactoferrin In The Reduction Of Pain

Resumes

Managing Partner

Atul Varadhachary

Youtube

Atul Varadhachary Managing Partner at Fannin ...

WeAreDevelopers Tech Leader: Atul Bhardwaj, C...

President - Tanvi Varadhachary

IDDD Roundtable Workshop: Starting a Biotech ...

The Emerging Era of Personalized Medicine

ATUL AND AARATI RING CEREMONY

Facebook

Atul Varadhachary

Plaxo

Atul Varadhachary

Googleplus

Atul Varadhachary